Heronova Pharmaceuticals

HeraNova Lifesciences is a clinical-stage biotechnology company dedicated to developing innovative diagnostic and therapeutic solutions for women's health. The company focuses on addressing significant unmet medical needs in conditions such as endometriosis, adenomyosis, and bacterial vaginosis. By leveraging a precision medicine approach, HeraNova aims to provide non-hormonal treatment options and non-invasive diagnostic tools to improve patient outcomes. The company operates with a global footprint, maintaining headquarters and R&D facilities in both the United States and China. Their integrated "Dx/Tx" model seeks to provide a comprehensive continuum of care, from early detection to targeted therapy. Founded by industry veterans, HeraNova is positioned to bridge the gap between advanced diagnostics and effective treatments in the underserved women's health sector.